Company news

Noxopharm Ltd. news in 2024

Noxopharm Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Additional convertible note for long-term shareholder

November 4, 2024

September 2024 Quarterly Activities report and Appendix 4C

October 28, 2024

New funding from sophisticated investors

September 27, 2024

Advanced funding secured ahead of R&D rebate

September 5, 2024

Significant results from new brain cancer drugs

September 2, 2024

Noxopharm Targets Clinical Trial for First-in-Class Drug

August 19, 2024

Significant CRO-67 Results in Pancreatic Cancer Studies

August 14, 2024

June 2024 Quarterly Activities Report and Appendix 4C

July 22, 2024

March 2024 Quarterly Activities Report and Appendix 4C

April 28, 2024

Appendix 4D and Half Year 2024 Financial Report

February 26, 2024

December 2023 Quarterly Activities Report and Appendix 4C

January 22, 2024

Decks in 2024